AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 53 filers reported holding AQUINOX PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $113,000 | -91.0% | 42,547 | -52.4% | 0.00% | -100.0% |
| Q1 2018 | $1,260,000 | +26.6% | 89,464 | +5.7% | 0.00% | +100.0% |
| Q4 2017 | $995,000 | -17.2% | 84,644 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $1,201,000 | +0.8% | 84,644 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,191,000 | -15.7% | 84,644 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,413,000 | +0.8% | 84,644 | -0.4% | 0.00% | 0.0% |
| Q4 2016 | $1,402,000 | +33.3% | 84,944 | +7.9% | 0.00% | 0.0% |
| Q3 2016 | $1,052,000 | – | 78,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 877,753 | $11,727,000 | 5.26% |
| RA Capital Management | 2,191,977 | $29,285,000 | 3.02% |
| NEXTHERA CAPITAL LP | 340,000 | $4,542,000 | 2.79% |
| Opaleye Management Inc. | 310,000 | $4,142,000 | 2.17% |
| Baker Brothers Advisors | 10,536,092 | $140,762,000 | 1.28% |
| Ghost Tree Capital, LLC | 250,000 | $3,340,000 | 0.54% |
| Cormorant Asset Management, LP | 151,838 | $2,029,000 | 0.22% |
| DAFNA Capital Management LLC | 20,000 | $267,000 | 0.19% |
| ELLINGTON MANAGEMENT GROUP LLC | 10,800 | $144,000 | 0.04% |
| Alyeska Investment Group, L.P. | 272,163 | $3,636,000 | 0.03% |